Resveratrol, a naturally occurring polyphenol, has been extensively studied for its anti-leukemic activity in CML, particularly through its effects on BCR-ABL-dependent signaling. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.